| IMM Stock | | | 1.12 0.01 0.88% |
ImmuPharma PLC financial indicator trend analysis is infinitely more than just investigating ImmuPharma PLC recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ImmuPharma PLC is a good investment. Please check the relationship between ImmuPharma PLC Research Development and its Gross Profit accounts. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmuPharma PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of economic analysis.
Research Development vs Gross Profit
Research Development vs Gross Profit Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
ImmuPharma PLC Research Development account and
Gross Profit. At this time, the significance of the direction appears to have very week relationship.
The correlation between ImmuPharma PLC's Research Development and Gross Profit is 0.28. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Gross Profit in the same time period over historical financial statements of ImmuPharma PLC, assuming nothing else is changed. The correlation between historical values of ImmuPharma PLC's Research Development and Gross Profit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of ImmuPharma PLC are associated (or correlated) with its Gross Profit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit has no effect on the direction of Research Development i.e., ImmuPharma PLC's Research Development and Gross Profit go up and down completely randomly.
Correlation Coefficient | 0.28 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Research Development
Gross Profit
Gross profit is a required income statement account that reflects total revenue of ImmuPharma PLC minus its cost of goods sold. It is profit before ImmuPharma PLC operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.
Most indicators from ImmuPharma PLC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ImmuPharma PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmuPharma PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of economic analysis.
The current year's
Selling General Administrative is expected to grow to about 1.7
M, whereas
Tax Provision is forecasted to decline to (522
K).
ImmuPharma PLC fundamental ratios Correlations
Click cells to compare fundamentals
ImmuPharma PLC Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ImmuPharma PLC fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in ImmuPharma Stock
Balance Sheet is a snapshot of the
financial position of ImmuPharma PLC at a specified time, usually calculated after every quarter, six months, or one year. ImmuPharma PLC Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of ImmuPharma PLC and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which ImmuPharma currently owns. An asset can also be divided into two categories, current and non-current.